The Indian domestic formulation market is expected to report robust growth with rising income levels, improving living standards, improved medical infrastructure, increasing health insurance penetration and the growing number of organized retail chains. The outlook for the domestic demand for drugs consumption looks extremely favorable. The market is further projected to grow at a CAGR of 13.1% over the next 5 years to reach USD 11.2 billion by 2011-12 driven by a series of socioeconomic factors
NLL’s branded generics division caters to this growing market with a range of branded generics. NLL branded generic division offers entire product range for all therapeutic area covering PAN India operations.